LENZ Therapeutics Inc (LENZ) support and resistance · rev $19.1M
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
This page maps LENZ Therapeutics Inc (LENZ) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LENZ revenue for 2025-12-31 was $19.1M. Net income was -$82.1M. LENZ currently screens at market cap $223.6M.
LENZ currently screens at market cap $223.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LENZ 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LENZ quote page for the session range and the stock page for the full model.
Not investment advice.